Patent · US Active

Compounds for treating spinal muscular atrophy

US9586955B2 · kind B2 · utility

18Cited by

9References

21Claims

0Family size

Assignees

PTC THERAPEUTICS, INC. · US
F. Hoffmann-La Roche AG · CH

Inventors

Hongyan Qi · Plainsboro, US
Soongyu Choi · Skillman, US
Amal Dakka · Whitehouse Station, US
Gary Mitchell Karp · Princeton, US
Jana Narasimhan · Scotch Plains, US
Nikolai Naryshkin · East Brunswick Township, US
Anthony Turpoff
Marla L. Weetall · Morristown, US
Ellen Welch · Califon, US
Matthew G. Woll · Madison, US
Tianle Yang · Mountainside, US
Nanjing Zhang · Princeton, US
Xiaoyan Zhang · Lexington, US
Xin Zhao · Austin, US
Luke Green · Basel, CH
Emmanuel Pinard · Rixheim, FR
Hasane Ratni · Habsheim, FR

Key dates

Filing date	Feb 8, 2013
Grant date	Mar 7, 2017
Priority date	—
Expiry date	Feb 8, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D519/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are compounds of Formula (I):and forms thereof, including compositions thereof and uses therewith for treating spinal muscular atrophy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.